These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26071229)

  • 21. UK Renal Registry 16th annual report: chapter 5 comorbidities and current smoking status amongst patients starting renal replacement therapy in England, Wales and Northern Ireland from 2011 to 2012.
    Rao A; Steenkamp R; Caskey F
    Nephron Clin Pract; 2013; 125(1-4):99-110. PubMed ID: 24662169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peritoneal dialysis is the best cost-effective alternative for maintaining dialysis treatment.
    Arrieta J; Rodríguez-Carmona A; Remón C; Pérez-Fontán M; Ortega F; Sánchez Tomero JA; Selgas R
    Nefrologia; 2011; 31(5):505-13. PubMed ID: 21959716
    [No Abstract]   [Full Text] [Related]  

  • 23. Peritoneal Dialysis as the Dialysis Initial Modality of Choice for Renal Replacement Therapy Initiation: Moving from "Why" to "Why Not".
    Subramanian S; Javaid MM
    Blood Purif; 2017; 44(2):106-107. PubMed ID: 28448966
    [No Abstract]   [Full Text] [Related]  

  • 24. Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore.
    Yang F; Lau T; Luo N
    Nephrology (Carlton); 2016 Aug; 21(8):669-77. PubMed ID: 26566750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?
    Kent S; Schlackow I; Lozano-Kühne J; Reith C; Emberson J; Haynes R; Gray A; Cass A; Baigent C; Landray MJ; Herrington W; Mihaylova B;
    BMC Nephrol; 2015 Apr; 16():65. PubMed ID: 25924679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. UK Renal Registry 13th Annual Report (December 2010): Chapter 4: comorbidities and current smoking status amongst patients starting renal replacement therapy in England, Wales and Northern Ireland from 2008 to 2009.
    Webb L; Gilg J; Feest T; Fogarty D
    Nephron Clin Pract; 2011; 119 Suppl 2():c85-96. PubMed ID: 21894042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost of renal replacement: how to help as many as possible while keeping expenses reasonable?
    Vanholder R; Lameire N; Annemans L; Van Biesen W
    Nephrol Dial Transplant; 2016 Aug; 31(8):1251-61. PubMed ID: 26109485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Public-private partnership in Hungarian dialysis care.
    Boncz I; Sebestyén A; Pintér I
    Nephrol Dial Transplant; 2006 Jul; 21(7):2024-5; author reply 2025. PubMed ID: 16644780
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cost-effectiveness analysis of various strategies of end-stage renal disease patients' care in France].
    Bongiovanni I; Couillerot-Peyrondet AL; Sambuc C; Dantony E; Elsensohn MH; Sainsaulieu Y; Ecochard R; Couchoud C
    Nephrol Ther; 2016 Apr; 12(2):104-15. PubMed ID: 26915892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health care costs of peritoneal dialysis technique failure and dialysis modality switching.
    Chui BK; Manns B; Pannu N; Dong J; Wiebe N; Jindal K; Klarenbach SW
    Am J Kidney Dis; 2013 Jan; 61(1):104-11. PubMed ID: 22901772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chapter 13 The linkage of incident renal replacement therapy patients in England (2002-2006) to hospital episodes and national mortality data: improved demography and hospitalisation data in patients undergoing renal replacement therapy.
    Fotheringham J; Fogarty D; Jacques R; El Nahas M; Campbell M
    Nephron Clin Pract; 2012; 120 Suppl 1():c247-60. PubMed ID: 22964571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comprehensive approach to assess the costs of renal replacement therapy for end-stage renal disease in France: the importance of age, diabetes status, and clinical events.
    Couillerot-Peyrondet AL; Sambuc C; Sainsaulieu Y; Couchoud C; Bongiovanni-Delarozière I
    Eur J Health Econ; 2017 May; 18(4):459-469. PubMed ID: 27146313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An analysis of the effectiveness and benefits of peritoneal dialysis and haemodialysis using Nigerian made PD fluids.
    Arogundade FA; Ishola DA; Sanusi AA; Akinsola A
    Afr J Med Med Sci; 2005 Sep; 34(3):227-33. PubMed ID: 16749353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients.
    Beddhu S; Bruns FJ; Saul M; Seddon P; Zeidel ML
    Am J Med; 2000 Jun; 108(8):609-13. PubMed ID: 10856407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Global differences in dialysis modality mix: the role of patient characteristics, macroeconomics and renal service indicators.
    van de Luijtgaarden MW; Jager KJ; Stel VS; Kramer A; Cusumano A; Elliott RF; Geue C; MacLeod AM; Stengel B; Covic A; Caskey FJ
    Nephrol Dial Transplant; 2013 May; 28(5):1264-75. PubMed ID: 23543592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cost of caring for end-stage kidney disease patients: an analysis based on hospital financial transaction records.
    Bruns FJ; Seddon P; Saul M; Zeidel ML
    J Am Soc Nephrol; 1998 May; 9(5):884-90. PubMed ID: 9596087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Employment of patients receiving maintenance dialysis and after kidney transplant: a cross-sectional study from Finland.
    Helanterä I; Haapio M; Koskinen P; Grönhagen-Riska C; Finne P
    Am J Kidney Dis; 2012 May; 59(5):700-6. PubMed ID: 21958597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal replacement therapy in Brunei Darussalam: comparing standards with international renal registries.
    Tan J
    Nephrology (Carlton); 2014 May; 19(5):288-95. PubMed ID: 24641721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost consideration in renal replacement therapy in Kenya.
    Were AJ; McLigeyo SO
    East Afr Med J; 1995 Jan; 72(1):69-71. PubMed ID: 7781562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. UK Renal Registry 11th Annual Report (December 2008): Chapter 6 Comorbidities and current smoking status amongst patients starting renal replacement therapy in England, Wales and Northern Ireland: national and centre-specific analyses.
    Udayaraj U; Tomson CR; Gilg J; Ansell D; Fogarty D
    Nephron Clin Pract; 2009; 111 Suppl 1():c97-111. PubMed ID: 19542707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.